JonathanDavisHF Profile Banner
Jonathan Davis, MD, MPHS Profile
Jonathan Davis, MD, MPHS

@JonathanDavisHF

Followers
3K
Following
14K
Media
98
Statuses
3K

Director @sfhealthnetwork HF Program Zuckerberg SF General Hospital @zsfgcare @ucsfcardiology. New Dad x2! Alum @WUSTLmed⬅️ @UCSFmedicine⬅️ @cornell he/his/him

San Francisco, CA
Joined April 2014
Don't wanna be here? Send us removal request.
@JonathanDavisHF
Jonathan Davis, MD, MPHS
5 years
The 3 rules of #GDMTWorks for #HFrEF: 1. Start more 2.⬆️doses 3. Keep them going #QuadTherapy: BB + ARNI + MRA + SGLT2-I. 75% RR reduction w NNT of <4!! @gcfmd @MKIttlesonMD @AndrewJSauer @AminYehyaMD @mpsotka @DrNasrien @shwinner @ShelleyZieroth @iamritu @DevinMehta @datsunian
12
39
203
@SJGreene_md
Steve Greene
16 days
@AndrewFoy82 @gcfmd @mvaduganathan @AndrewJSauer @dranulala @ShelleyZieroth @JavedButler1 @pedschwartzmann @JonathanDavisHF @HFA_President @ankeetbhatt To Mandrola's original point: 🔑is definition of "decompensated" We should not initiate BB in hemodynamic instability/shock But "decompensated" is not synonymous w/ entirety of a HF hospitalization. In-hospital/pre-discharge initiation BB is evidence-based routine approach.
0
1
8
@HanCardiomd
Henry Han
16 days
Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction https://t.co/8Y0G6ZroG8
1
19
66
@JonathanDavisHF
Jonathan Davis, MD, MPHS
16 days
Excited to formally launch our #HeartFailure Clinic at @FollowMercy St. Louis. Offering comprehensive, state-of-the-art, guideline-direct care for anyone with heart failure across the ejection fraction spectrum! #heartfunction #heartsuccess
0
0
23
@mvaduganathan
Muthu Vaduganathan
16 days
β-blockers safe pre-discharge in #HFrEF #COPERNICUS ☠️ benefit in recent decomp https://t.co/RPAODKmbNj #STRONGHF rapid uptritration ⬇️ events https://t.co/2EGk0obyDg #IMPACTHF ⬆️ Rx persistence https://t.co/pc0wJkfY7U #BCONVINCED stopping not helpful https://t.co/GdMoEu5qr8
@drjohnm
John Mandrola, MD
17 days
Heart failure colleagues. I would propose a new focus of emphasis Re the acute Rx of newly decompensated systolic failure. We should favor afterload reduction FIRST. Seminal Beta-blocker trials were in ambulatory outpts. Giving BB to decompensated failure is a mistake. IMO.
4
25
112
@JonathanDavisHF
Jonathan Davis, MD, MPHS
1 month
9/29 I start at Mercy St. Louis! Working at @UCSFHospitals/@ZSFGCare/@UCSFCardiology was a profound privilege. The community, patients, & colleagues gave me more than I can ever express. Please know how grateful I am to have been part of this extraordinary team.
8
3
30
@noshreza
Nosheen Reza, MD, MS
3 months
Pop in for any part of the hour — we’re excited to connect with you and chat about the amazing things we have going on at @JCFINT! @HFSA @JasonKatzMD @ElliottMillerMD @SarahChuzi @ShahzebKhanMD @JulieDoberne @hcg_md @Carnicelli_Ant @MartyTamMD @JonathanDavisHF @FarhanRazaMD
@JCFINT
JCF Intersections
3 months
Join Editor in Chief @JasonKatzMD and Deputy Editor @noshreza for JCF-I Office Hours! Answering your questions on: ✅the journal’s inaugural publications ✅what they are looking for in submissions ✅exciting updates on what’s to come 🔗 Registration: https://t.co/vj78YnE8Zq
0
7
21
@SeguraCardio
Diego Segura-Rodríguez
3 months
🚨🚨🚨 Just released: 2025 AHA/ACC Multisociety Guideline on High Blood Pressure in Adults‼️ A must-read update for all clinicians. Love this post? I appreciate sharing & following ❤️ #Hypertension #CardioTwitter #HTN2025 #AHA
3
49
125
@noshreza
Nosheen Reza, MD, MS
3 months
Our 4th @JCFINT manuscript is now in press! 🚀 @MayoCVservices describes their experience with renal replacement therapy in patients with cardiogenic shock Important research at the intersection of 🫀+🫘 care! @HFSA @JasonKatzMD @ElliottMillerMD @SarahChuzi @ShahzebKhanMD
@JCFINT
JCF Intersections
3 months
Among 1,498 CICU patients with cardiogenic shock, the need for renal replacement therapy (RRT)—especially CRRT—is strongly associated with worse outcomes. 📉 In-hospital mortality for CRRT: 56% 📈 One-year survival: <30% 🧵 Key findings below: 🔗 https://t.co/oWboLwwHVZ
1
6
23
@ankeetbhatt
Ankeet S. Bhatt, MD, MBA
3 months
Does timing of #GDMTworks affect economic value? In @JCardFail from #DELIVER, we examine #CostEffectiveness of #SGLT2i by time from #HF Hosp in pts with HFmrEF/HFpEF. Earlier initiation associated with: 🎯 Lower HF-related costs & 🎯Greater economic value #initiateNOW
1
7
32
@JasonKatzMD
Jason N. Katz
3 months
It’s finally here! Bite-sized podcasts on high-yield Critical Care Cardiology topics! Whether you are commuting to work, taking a break from resuscitation, or leaving at the end of a long day - take a listen to these casual conversations full of education from amazing colleagues!
@SocietyOfCCC
Society Of Critical Care Cardiology
3 months
🚨 IT’S HERE! 🚨 The wait is over...the podcast episode that’s about to break the internet has officially dropped! 🎙 🎧 Listen now: https://t.co/uqJsMDV2zG Join us on Pre-Rounds Podcast hosted by @BalimSenmanMD, as @ElliottMillerMD breaks down VT Storm with life-saving tips for
4
10
57
@JeffreyLDavis44
Jeffrey Davis
3 months
Regs & Eggs is out! https://t.co/OOqOrfSbF9 This week, I provide a high-level overview of the CY 2026 Medicare Physician Fee Schedule Proposed Rule as well as some key takeaways. Stakeholders have highly anticipated the release of this rule, as it represents the Trump
Tweet card summary image
mcdermottplus.com
Explore takeaways from CMS’s CY 2026 Medicare Physician Fee Schedule proposed rule, including payment updates, telehealth, MIPS, and more.
@McDermottPlus
McDermott+
3 months
🚨 New Regs & Eggs is here! Jeffrey Davis breaks down the CY 2026 Medicare PFS Proposed Rule—Trump admin’s first big move on physician payment. 🍳📜 📖 Read the highlights: https://t.co/kEg8lZVdDg
0
2
9
@mvaduganathan
Muthu Vaduganathan
4 months
Just 5 years ago, HFpEF was described as the “stepchild” of HF with no approved therapies. Today, there are 5 US FDA therapies: ✅ Empagliflozin (#EMPEROR) ✅ Dapagliflozin (#DELIVER) ✅ Sotagliflozin (#SOLOISTWHF) ✅ Sacubitril/Valsartan (#PARAGONHF) ✅ Finerenone (#FINEARTSHF)
12
158
607
@AminYehyaMD
Amin Yehya, MD, MS, FACC, FHFSA
4 months
Excited to share our latest publication in #JACCCaseReports on how home #hospice is an underutilized option for patients with #LVAD in end-of-life. This was a collaborative work with our phenomenal #palliativecare team @EVMSMedicine! @JACCJournals ➡️Link: https://t.co/hmoxLNPFZb
6
10
31
@SantosGallegoMD
Carlos G Santos-Gallego, MD
4 months
Do not miss this Virtual Grand Rounds! @rachkataria is a superstar!
@CASivaram1
Chittur Sivaram MD MACP MACC
4 months
🤩 We close current academic year with OU Virtual CV GR by Early Career 🌟 Dr. Rachna Kataria from Brown University 🤩 Join us on 6/26/25 to learn about CS care at non-VAD non-transplant centers https://t.co/RapB2kLFyu @OUCollegeofMed @rachkataria @AHajduczok @hvanspall
1
2
15
@JonathanDavisHF
Jonathan Davis, MD, MPHS
4 months
Congratulations to the @UCSFMedicine @UCSFIMChiefs Interns on completing intern year!! A major achievement and milestone. Enjoy your week away, you earned it!!
0
0
7
@dranulala
Anu Lala (Anuradha Lala-Trindade)
5 months
Vulnerable share: Change is always hard. Kids grow older. Schools change. Trainees move on. New challenges. The natural response? RESISTANCE. The more effective empowering response? Acceptance. 🙏🏽💜(working on it 🫣) Go easy on yourself during this time of transition 🌊
7
7
79
@AHajduczok
Alexander Hajduczok, MD 🇺🇦🙏
5 months
Buckle up for 15+ years of my research journey… This is a story of how an unfinished PhD ultimately led to a passion for remote monitoring and a love for hemodynamics (and much more) ❤️ @RyanTedfordMD @AndrewJSauer @robmentz @JennaSkowronski @JeffTeuteberg @noshreza @dranulala
@CASivaram1
Chittur Sivaram MD MACP MACC
5 months
4
11
56
@JonathanDavisHF
Jonathan Davis, MD, MPHS
5 months
Honored beyond words to receive the 2025 @UCSFMedicine @UCSF at @ZSFGCare Exceptional Physician Award. It is an incredible privilege to work alongside everyone across the SFHN. Thank you! @UCSFIMChiefs @UCSFCardiology
7
3
42
@AminYehyaMD
Amin Yehya, MD, MS, FACC, FHFSA
6 months
Excellent summary of the current literature! Very informative, strong work! @jllbmd @totocarbone @JonathanDavisHF
@jllbmd
Jose L. Lopez, MD
6 months
Check our latest review published in US Cardiology the #official @CardioNerds @radcliffeCARDIO journal diving into the expanding role of #SGLT2i and #GLP1RA in #HF Shoutout to my amazing co-authors ➡️ @tracymakMD @JonathanDavisHF @totocarbone Special thanks to @AminYehyaMD
1
1
9
@AHajduczok
Alexander Hajduczok, MD 🇺🇦🙏
6 months
@jllbmd
Jose L. Lopez, MD
6 months
Check our latest review published in US Cardiology the #official @CardioNerds @radcliffeCARDIO journal diving into the expanding role of #SGLT2i and #GLP1RA in #HF Shoutout to my amazing co-authors ➡️ @tracymakMD @JonathanDavisHF @totocarbone Special thanks to @AminYehyaMD
1
2
8